IMAGE

Fig. 8.

ID: ZDB-IMAGE-230707-37
Publication: Zhang et al., 2023 - A zebrafish model of Combined Saposin Deficiency identifies acid sphingomyelinase as a potential therapeutic target
All Figures: Figures for Zhang et al., 2023

Image

Figure Caption

Fig. 8.

Schematic of the proposed sequence of events driving disease progression in the combined saposin deficiency zebrafish model. Increased tnfb and il1b expression is detected at ∼22 dpf in the psap^−/− brain, followed by increased expression of additional neuroinflammatory markers (stat2, stat3, socs1a, nfkbiaa, cd45 and cd68) and loss of myelin (reduced mbpa) at ∼1 mpf; these pathologies worsen over time, preceding loss of neuronal markers (gfap, rbfox3a) and dysregulated mTORC1 signaling at ∼4 mpf, fairly rapid onset of cachexia and locomotion impairment within 2 weeks around the 4-mpf time point, and death of all psap^−/− fish by 5 mpf. Knockout of acid sphingomyelinase (smpd1) in psap^−/− zebrafish leads to a modest increase in lifespan via yet to be investigated mechanisms.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dis. Model. Mech.